Company Profile
Public information reviewedAcrivon Therapeutics, Inc.
Acrivon Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company primarily focused on creating oncology treatments.
USNASDAQ: ACRV
Follow
More
- Public sources
- 1 reviewed
- Published leadership records
- 8
- Last reviewed
- Sep 12, 2026

